Atlanta Braves Holdings, Inc. EVP of Development Michael P. Plant filed a Form 4 on November 12, 2026, disclosing option exercises and open-market sales of Series C Common Stock conducted November 9 through November 11, 2026, pursuant to a Rule 10b5-1 sales plan.

Key Highlights

  • Three-day exercise and sale: Plant exercised stock options and sold Series C Common Stock on November 9, 10, and 11, 2026, under a Rule 10b5-1 plan adopted August 7, 2026.
  • Total shares sold: 129,395 shares of Series C Common Stock were disposed of across the three days (57,395 on November 9, 57,000 on November 10, and 15,193 indirectly on November 11, plus 57,000 directly on November 11).
  • Weighted average sale prices: $51.28 on November 9 (range $50.43-$52.04), $52.21 on November 10 (range $51.57-$52.62), and $51.79 on November 11 (range $51.36-$52.13).
  • Option exercise price: All options exercised carried a conversion price of $27.18 per share, with an expiration date of December 10, 2027.
  • Remaining options: Following the reported transactions, Plant held 114,000 stock options (right to buy BATRK) directly.
  • Amended holdings disclosure: The filing notes that 23,925 shares returned from a Grantor Retained Annuity Trust on December 7, 2023, were "inadvertently not reflected" in previously reported holdings.

Plant's Option Exercises and Stock Sales at Atlanta Braves Holdings

According to the filing, Michael P. Plant, Executive Vice President of Development at Atlanta Braves Holdings, Inc. (NASDAQ:BATRK), exercised stock options and sold shares of Series C Common Stock over three consecutive trading days. All sales identified by the filing's footnote were conducted under a Rule 10b5-1 sales plan that Plant adopted on August 7, 2026. The options exercised each carried an exercise price of $27.18 and were originally exercisable beginning December 10, 2023, with an expiration of December 10, 2027.

On November 9, 2026, the filing reports Plant exercised 57,395 options (transaction code M) and sold 57,395 shares at a weighted average price of $51.28 per share. On November 10, 2026, he exercised 57,000 options and sold 57,000 shares at a weighted average of $52.21. On November 11, 2026, he exercised an additional 57,000 options and sold 57,000 shares directly at a weighted average of $51.79, plus 15,193 shares held indirectly through a Grantor Retained Annuity Trust at $52.00 per share. Following all reported transactions, Plant held 285,903 shares directly and zero shares indirectly through the GRAT.

The filing also discloses a correction to previously reported beneficial ownership. According to the explanation of responses, 23,925 shares returned from Plant's GRAT on December 7, 2023, and 16,385 shares returned on November 10, 2026, in satisfaction of annuity obligations were either previously omitted or are now being reflected. The filing states those shares were "inadvertently not reflected in the reporting person's previously reported holdings."

What Was Disclosed

The Form 4 discloses option exercises totaling 171,395 shares and open-market sales totaling 129,395 shares of Atlanta Braves Holdings Series C Common Stock by EVP Michael P. Plant between November 9 and November 11, 2026, plus a correction to previously omitted GRAT-related share holdings.